Drugs / Monovalent Avian Influenza VLP (H5N1)
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01596725 | May → Aug 2012 | influenza | Novavax | Completed | No outcome recorded |
| Phase 1 | NCT01594320 | Apr → Jul 2012 | influenza | Novavax | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent Avian Influenza VLP (H5N1) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01596725 ↗ |
| Modality | Vaccine | “Avian flu vaccine” NCT01594320 ↗ |
| Route | Intramuscular | “intramuscular, deltoid” NCT01594320 ↗ |